Anti-apoptotic and Anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson's Rat model

Journal of Nutritional Biochemistry

Volumn 24, Issue 4, 2013, Pages 680-687

  Shrivastava, Pallavi ^a,c   Vaibhav, Kumar ^a   Tabassum, Rizwana ^a   Khan, Andleeb ^a   Ishrat, Tauheed ^a,d   Khan, Mohd Moshahid ^a,e   Ahmad, Ajmal ^a,f   Islam, Farah ^a   Safhi, Mohammed M ^b   Islam, Fakhrul ^a  

^a HAMDARD UNIVERSITY   (India)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c OKLAHOMA STATE UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

6 OHDA; Caspase 3 9; Cytochrome c; IL 1 ; Piperine; Poly(ADP ribose) polymerase; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CASPASE 3; CASPASE 9; CYTOCHROME C; GLUTATHIONE; INTERLEUKIN 1BETA; PIPERINE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN OXYGEN CONSUMPTION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DNA STRAND BREAKAGE; ENZYME ACTIVATION; LIPID PEROXIDATION; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT;

ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOMORPHINE; APOPTOSIS; BEHAVIOR, ANIMAL; BENZODIOXOLES; DISEASE MODELS, ANIMAL; MALE; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR;

PIPER NIGRUM; RATTUS;

EID: 84875083595     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.03.018     Document Type: Article

References (55)

1. Olanow C.W. The pathogenesis of cell death in Parkinson's disease. Mov Disord 2007, 22:335-342.
2. Olanow C.W., Stern M.B. Parkinson's disease: unresolved issues. Ann Neurol 2008, 64:1-2.
3. Hirsch E.C., Hunot S., Faucheux B., Agid Y., Mizuno Y., Mochizuki H., Tatton W.G., Tatton N., Olanow C.W. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord 1999, 14(2):383-385.
4. Miller R.L., James-Kracke M., Sun G.Y., Sun A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 2009, 34(1):55-65.
5. Hanrott K., Gudmunsen L., O'Neill M.J. Wonnacott S.6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 2006, 281(9):5373-5382.
6. Bayir H., Kapralov A.A., Jiang J., Huang Z., Tyurina Y.Y., Tyurin V.A., Zhao Q., Belikova N.A., Vlasova I.I., Maeda A., Zhu J., Na H.M., Mastroberardino P.G., Sparvero L.J., Amoscato A.A., Chu C.T., Greenamyre J.T., Kagan V.E. Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem 2009, 284(23):15951-15969.
7. Fahn S., Oakes D., Shoulson I., Kieburtz K., Rudolph A., Lang A., Olanow C.W., Tanner C., Marek K. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004, 351(24):2498-2508.
8. Olanow C.W. The scientific basis for the current treatment of Parkinson's disease. Annu Rev Med 2004, 55:41-60.
9. Schapira A.H., Olanow C.W. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 2004, 291(3):358-364.
10. Ahmad M., Saleem S., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., Ishrat T., Chaturvedi R.K., Agrawal A.K., Islam F. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 2005, 93(1):94-104.
11. Ahmad M., Yousuf S., Khan M.B., Hoda M.N., Ahmad A.S., Ansari M.A., Ishrat T., Agrawal A.K., Islam F. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav 2006, 83(1):150-160.
12. Ahmad M., Saleem S., Ahmad A.S., Ansari M.A., Yousuf S., Hoda M.N., Islam F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 2005, 24(3):137-147.
13. Lee E.B., Shin K.H., Woo W.S. Pharmacological study on piperine. Arch Pharm Res 1984, 7(2):127-132.
14. Woo W.S., Lee E.B., Shin K.H. Central nervous depressant activity of piperine. Arch Pharm Res 1979, 2:121-125.
15. Noguchi N., Komuro E., Etsuo N., Willson R.L. Action of curcumin as an antioxidant against lipid peroxidation. J Jpn Oil Chem Soc. 1994, 43:1045-1051.
16. Vijayakumar R.S., Surya D., Nalini N. Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep 2004, 9:105-110.
17. Pathak N., Khandelwal S. Cytoprotective and immunomodulating properties of piperine on murine splenocytes: an in vitro study. Eur J Pharmacol 2007, 576(1-3):160-170.
18. Bajad S., Bedi K.L., Singla A.K., Johri R.K. Antidiarrhoeal activity of piperine in mice. Planta Med 2001, 67:284-287.
19. Bai Y.F., Xu H. Protective action of piperine against experimental gastric ulcer. Acta Pharmacol Sin 2000, 21(4):357-359.
20. Atal C.K., Dubey R.K., Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 1985, 232(1):258-262.
21. Hu Y., Liao H.B., Liu P., Guo D.H., Wang Y.Y. Antidepressant effects of piperine and its neuroprotective mechanism in rats. Zhong Xi Yi Jie He Xue Bao 2009, 7(7):667-670.
22. Chonpathompikunlert P., Wattanathorn J., Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease. Food Chem Toxicol 2010, 48(3):798-802.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1987, Academic Press, San Diego, CA.
24. Ziegler M.G., Szechtman H. Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system. Behav Brain Res 1990, 39(2):123-133.
25. Fernagut P.O., Diguet E., Bioulac B., Tison F. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Exp Neurol 2004, 185:47-62.
26. Rozas G., Lopez-Martin E., Guerra M.J., Labandeira-Garcia J.L. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods 1998, 83:165-175.
27. Rauscher F.M., Sanders R.A., Watkins J.B. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2000, 14(6):329-334.
28. Utley H.C., Bernheim F., Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 1967, 260:521-531.
29. Jollow D.J., Mitchell J.R., Zampagloine N., Gillete J.R. Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 1974, 11:151-169.
30. Masmoudi A., Islam F., Mandal P. ADP-Ribosylation of high purified rat brain mitochondria. J Neurochem 1988, 51:188-193.
31. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193(1):265-275.
32. Burnette W.N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981, 112(2):195-203.
33. Szabó C., Wong H.R., Salzman A.L. Pre-exposure to heat shock inhibits peroxynitrite-induced activation of poly(ADP) ribosyltransferase and protects against peroxynitrite cytotoxicity in J774 macrophages. Eur J Pharmacol 1996, 315(2):221-226.
34. Ha H.C., Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999, 96:13978-13982.
35. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., Dawson V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (Wash DC). 2002, 297:259-263.
36. Lin T.K., Liou C.W., Chen S.D., Chuang Y.C., Tiao M.M., Wang P.W., Chen J.B., Chuang J.H. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease. Chang Gung Med J 2009, 32(6):589-599.
37. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129(2):154-169.
38. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989, 86:6348-6352.
39. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol. 2007, 2(2):140-153.
40. Pott Godoy M.C., Tarelli R., Ferrari C.C., Sarchi M.I., Pitossi F.J. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008, 131:1880-1894.
41. Fornaguera J., Schwarting R.K.W., Boix F., Huston J.P. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model. Synapse 1993, 13:179-185.
42. Whishaw I.Q., Li K., Whishaw P.A., Gorny B., Metz G.A. Use of rotorod as a method for the qualitative analysis of walking in rat. J Vis Exp. 2008, 22:1030.
43. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol. 2003, 53(3):26-36.
44. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 1995, 45(8):1594-1601.
45. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. Journal of Neuroscience. 2001, 21(9):3017-3023.
46. Lyras L., Perry R.H., Perry E.K., Ince P.G., Jenner A., Jenner P., Halliwell B. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. Journal of Neurochemistry. 1998, 71(1):302-312.
47. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996, 93:2696-2701.
48. Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem. 1997, 69:1326-1329.
49. Porter A.G., Jänicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999, 6(2):99-104.
50. Eskes R., Antonsson B., Osen-Sand A., Montessuit S., Richter C., Sadoul R., Mazzei G., Nichols A., Martinou J.C. Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J Cell Biol. 1998, 143(1):217-224.
51. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998, 281:1322-1326.
52. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988, 38:1285-1291.
53. Bae G.S., Kim M.S., Jung W.S., Seo S.W., Yun S.W., Kim S.G., Park R.K., Kim E.C., Song H.J., Park S.J. Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. Eur J Pharmacol. 2010, 642(1-3):154-162.
54. Islam F., Zia S., Sayeed I., Zafar K.S., Ahmad A.S. Selenium-induced alteration of lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol Trace Elem Res. 2002, 90(1-3):203-214.
55. Wood A.B., Barrow M.L., James D.J. Piperine determination in pepper (Piper nigrum L.) and its oleoresins-a reversed-phase high-performance liquid chromatographic method. Flavour and Fragrance Journal 1988, 3(2):55-64.